More on M&A tickers, etc. Bristol Myers Squibb: Value Emerges From Distress Johnson & Johnson: A Safe Haven That's Quietly Becoming A Bit Overpriced Akero: Novo Nordisk Acquisition Puts Focus On Unprecedented MASH Data With EFX J&J urges shareholders to reject Tutanota 'mini-tender' offer Tech Voices: China probing Qualcomm, Apple sued over AI, rare earths